AstraZeneca Computational Pathology GmbH develops and uses AI-supported research, software and services to support and accelerate drug development and is registered in the Munich commercial register under HRB 251893. It provides exclusively intra-group research and development services based on a Research and Development Services Agreement with AstraZeneca AB, effective January 1, 2021. Its core competency is the development of biomarkers based on imaging methods as well as image analysis, machine learning, artificial intelligence, statistical modelling and other data-science techniques. In the 2024 financial year the company employed on average 140 staff, of which 130 worked in research and development.
Entwicklung und Nutzung von KI-gestützter Forschung, Software und Dienstleistungen zur Unterstützung und Beschleunigung der Arzneimittelentwicklung.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) München Local Court, HRB 251893 (as of 9 October 2026)
Source: German Commercial Register (Handelsregister) München Local Court, HRB 251893 (as of 9 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 251893 (as of 9 October 2026)
Eurofins Genomics Europe Pharma and Diagnostics Products & Services Sanger/PCR GmbH
Ebersberg · Forschung und Entwicklung im Bereich Biotechnologie
Dynavax GmbH
Düsseldorf · Forschung und Entwicklung im Bereich Biotechnologie
Scienion GmbH
Berlin · Forschung und Entwicklung im Bereich Biotechnologie
Sign in to view detailed salary and cost trends.
